# BioCaptiva

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocaptiva

- Industry: Biotechnology
- Headquarters: UK
- Website: www.biocaptiva.com
- Total disclosed funding: $4.2M
- Latest round: Seed (Jun 1, 2022)
- Investors on record: 3

## About

Based in St. Andrews, UK, and founded in 2018, BioCaptiva Limited operates as a developer of liquid biopsy technology devices designed to diagnose, monitor, and detect cancers. In March 2026, BioCaptiva Limited raised GBP 1.58 million in venture funding led by Archangels Investors Limited, with participation from Old College Capital, BBI Capital, Scottish Enterprise, and EverQuest Capital Partners.

BioCaptiva's BioCollector device captures cfDNA (circulating free DNA) from the blood of patients in much greater quantities than the standard of a single blood draw, overcoming a significant current limitation of cancer liquid biopsy testing, which leads to detecting cancer at the early stage.

The company plans to use the March 2026 funding to develop its blood sample preparation technology and expand its liquid biopsy product range following the launch of its first research kits in the U.S.

## Funding rounds

- Seed, Jun 1, 2022, $2.6M — Archangels Investors Limited, Old College Capital, Scottish Enterprise
- Seed, Mar 31, 2021, $1.5M — Archangels Investors Limited, Scottish Enterprise

## Investors

- Archangels Investors Limited — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed
- Old College Capital (https://capitalatlas.ai/funds/old-college-capital) — Seed